First Study to Use a pTau217 Blood Test to Detect Alzheimer’s Disease Early and at Scale CARLSBAD, Calif., Dec. 17, 2025 /PRNewswire/ — ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s and related diseases, today announced that the Simoa® ALZpath pTau217…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
